P3 Health Partners Inc. ( PIII ) Reports Q2 Loss, Lags Revenue Estimates
P3 Health Partners (PIII) delivered earnings and revenue surprises of -89.36% and -2.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Tempus AI ( TEM ) Reports Q2 Loss, Beats Revenue Estimates
Tempus (TEM) delivered earnings and revenue surprises of +4.35% and +5.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Senseonics Holdings ( SENS ) Reports Q2 Loss, Tops Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of 0.00% and +4.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
3 Red-Hot Growth Stocks to Buy in 2025
Growth stocks are one of the best ways for you to grow your portfolio and build a comfortable nest egg for retirement. However, you need to choose such stocks carefully to ensure that you pick gems and not duds.Certain characteristics should stand out to help you make your investment decision: a ...
All You Need to Know About Phreesia ( PHR ) Rating Upgrade to Buy
Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Phreesia ( PHR ) Upgraded to Buy: What Does It Mean for the Stock?
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Phreesia ( PHR ) Reports Q1 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 46.15% and 1.09%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Gear Up for Phreesia ( PHR ) Q1 Earnings: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.
Privia Health ( PRVA ) Misses Q1 Earnings Estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -50% and 5.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
TruBridge ( TBRG ) Lags Q1 Earnings Estimates
TruBridge (TBRG) delivered earnings and revenue surprises of -2.70% and 1.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Analysts Think Phreesia ( PHR ) Could Surge 28.02%: Read This Before Placing a Bet
The consensus price target hints at a 28% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Company News for Mar 14, 2025
Companies in The News Are: QBTS, INTC, DG, PHR ...
Phreesia ( PHR ) Reports Q4 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 42.11% and 0.71%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
The Pennant Group, Inc. ( PNTG ) Q4 Earnings Miss Estimates
The Pennant Group (PNTG) delivered earnings and revenue surprises of -4% and 1.12%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Phreesia ( PHR ) Moves 5.6% Higher: Will This Strength Last?
Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Phreesia, Inc. ( PHR ) Soars to 52-Week High, Time to Cash Out?
Phreesia (PHR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
REPEAT: Treatment.com AI Enters Into a Binding Letter of Intent to Acquire Alea Health Holdings Limited adding an AI Powered Voice Agent and Mental Health to its Platform
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES ...
Treatment.com AI Enters Into a Binding Letter of Intent to Acquire Alea Health Holdings Limited adding an AI Powered Voice Agent and Mental Health to its Platform
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES ...
Treatment.com AI Enters Into a Binding Letter of Intent to Acquire Alea Health Holdings Limited adding an AI Powered Voice Agent and Mental Health to its Platform
• Proprietary Voice Agent using Conversational AI for onboarding and triaging patients • Advancing Mental Health Support using Alea's proprietary and AI powered Mental Health Platform to Augment Primary and Specialist Care
Zacks Industry Outlook Enovis, Omnicell and Phreesia
Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article.
3 Medical Info Systems Stocks to Buy as Stargate AI Drives Industry Prospects
Zacks Medical Info Systems industry stocks like Enovis, Omnicell and Phreesia are expected to gain from the GenAI wave.
Phreesia ( PHR ) Upgraded to Buy: Here's Why
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Buy Phreesia ( PHR ) After Golden Cross?
Is it a good or bad thing when a stock experiences a golden cross technical event?
Wall Street Analysts See a 25% Upside in Phreesia ( PHR ) : Can the Stock Really Move This High?
The consensus price target hints at a 25% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday - Columbia Sportswear ( NASDAQ:COLM ) , Intuitive Surgical ( NASDAQ:ISRG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for Walmart Inc. WMT from $96 to $100.
Phreesia ( PHR ) Reports Q3 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 13.79% and 0.76%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Curious about Phreesia ( PHR ) Q3 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of Phreesia (PHR) for the quarter ended October 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Sol-Gel Technologies Ltd. ( SLGL ) Reports Q3 Loss, Tops Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of 92.31% and 99.29%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Spero Therapeutics, Inc. ( SPRO ) Reports Q3 Loss, Lags Revenue Estimates
Spero Therapeutics (SPRO) delivered earnings and revenue surprises of -18.52% and 41.44%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Schrodinger, Inc. ( SDGR ) Reports Q3 Loss, Misses Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of -30% and 13.85%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Phreesia ( PHR ) Moves 13.9% Higher: Will This Strength Last?
Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CLOV Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
The continued strength in Clover Health's offerings is likely to have driven the company's performance in the third quarter.
HIMS Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
The continued solid uptake of Hims & Hers offerings and expanding subscriber base are likely to have driven the company's performance in the third quarter.
Down -10.25% in 4 Weeks, Here's Why Phreesia ( PHR ) Looks Ripe for a Turnaround
Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?
TDOC is well positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.
Phreesia ( PHR ) Reports Q2 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 16.22% and 0.35%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Phreesia ( PHR ) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Get a deeper insight into the potential performance of Phreesia (PHR) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Augmedix, Inc. ( AUGX ) Reports Q2 Loss, Lags Revenue Estimates
Augmedix (AUGX) delivered earnings and revenue surprises of -33.33% and 0.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
P3 Health Partners Inc. ( PIII ) Reports Q2 Loss, Tops Revenue Estimates
P3 Health Partners (PIII) delivered earnings and revenue surprises of -87.50% and 4.02%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Nyxoah SA ( NYXH ) Reports Q2 Loss, Misses Revenue Estimates
Nyxoah (NYXH) delivered earnings and revenue surprises of -2.22% and 56.88%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm - Helen Of Troy ( NASDAQ:HELE ) , Salesforce ( NYSE:CRM )
NEW YORK, Aug. 05, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Helen of Troy Limited HELE, Owens & Minor, Inc. OMI, Salesforce, Inc. CRM, and Phreesia, Inc.
Wall Street Analysts Think Phreesia ( PHR ) Could Surge 27.77%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 27.8% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR - Phreesia ( NYSE:PHR )
NEW YORK, July 12, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ( "Phreesia" or the "Company" ) PHR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Phreesia ( PHR ) Upgraded to Strong Buy: Here's What You Should Know
Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday - Costco Wholesale ( NASDAQ:COST )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Morgan Stanley cut the price target for Microchip Technology Incorporated MCHP from $102 to $100.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR - Phreesia ( NYSE:PHR )
NEW YORK, July 07, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ( "Phreesia" or the "Company" ) PHR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR - Phreesia ( NYSE:PHR )
NEW YORK, June 30, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ( "Phreesia" or the "Company" ) PHR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E - Applied DNA Sciences ( NASDAQ:APDN ) , Biodesix ( NASDAQ:BDSX )
Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings ( P/E ) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock value.
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).
5 Medical Info Systems Stock to Buy for a Stable Portfolio - Enovis ( NYSE:ENOV ) , Hims & Hers Health ( NYSE:HIMS )
The medical info systems industry is set to thrive in the second half of 2024 due to the growing demand for contactless services. The industry witnessed exponential growth during the pandemic era. Even in the post-pandemic period, remote healthcare, a paperless environment and distant treatment ...
